Despite an already strong run, Obio Technology (Shanghai) Corp., Ltd. (SHSE:688238) shares have been powering on, with a gain of 26% in the last thirty days. Unfortunately, the gains of the last month did little to right the losses of the last year with the stock still down 38% over that time.
Since its price has surged higher, when almost half of the companies in China’s Life Sciences industry have price-to-sales ratios (or “P/S”) below 5.5x, you may consider Obio Technology (Shanghai) as a stock not worth researching with its 15.6x P/S ratio. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the highly elevated P/S.
See our latest analysis for Obio Technology (Shanghai)
How Has Obio Technology (Shanghai) Performed Recently?
Recent times have been pleasing for Obio Technology (Shanghai) as its revenue has risen in…
